Connection

Solange Peters to Neoplasms

Back to Details
This is a "connection" page, showing publications Solange Peters has written about Neoplasms.
Solange Peters
Connection Strength
0.518
Neoplasms
  1. OncoAlert Round Table Discussions: The Global COVID-19 Experience. JCO Glob Oncol. 2021 04; 7:455-463.
    View in: PubMed
    Score: 0.117
  2. [Oncology: navigating the COVID-19 Pandemic and Steer the Course]. Rev Med Suisse. 2020 Apr 29; 16(N° 691-2):819-822.
    View in: PubMed
    Score: 0.110
  3. The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19. J Thromb Haemost. 2021 10; 19(10):2522-2532.
    View in: PubMed
    Score: 0.030
  4. Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic. Cancer Discov. 2021 06; 11(6):1330-1335.
    View in: PubMed
    Score: 0.029
  5. Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians. ESMO Open. 2020 12; 5(6):e001090.
    View in: PubMed
    Score: 0.029
  6. COVID-19 and Cancer: Current Challenges and Perspectives. Cancer Cell. 2020 11 09; 38(5):629-646.
    View in: PubMed
    Score: 0.028
  7. Survey of the Impact of COVID-19 on Oncologists' Decision Making in Cancer. JCO Glob Oncol. 2020 08; 6:1248-1257.
    View in: PubMed
    Score: 0.028
  8. Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. Cancer Discov. 2020 10; 10(10):1514-1527.
    View in: PubMed
    Score: 0.028
  9. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020 06 20; 395(10241):1907-1918.
    View in: PubMed
    Score: 0.028
  10. The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer. Cancer Cell. 2020 06 08; 37(6):738-741.
    View in: PubMed
    Score: 0.028
  11. [Oncology, what's new in 2018]. Rev Med Suisse. 2019 Jan 09; 15(N° 632-633):78-81.
    View in: PubMed
    Score: 0.025
  12. Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors. J Clin Oncol. 2018 10 20; 36(30):3007-3014.
    View in: PubMed
    Score: 0.024
  13. [2020 oncology update]. Rev Med Suisse. 2021 Jan 27; 17(723):201-205.
    View in: PubMed
    Score: 0.007
  14. New therapeutic perspectives to manage refractory immune checkpoint-related toxicities. Lancet Oncol. 2019 01; 20(1):e54-e64.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.